Beijing Scitop Bio-tech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Operating Revenue	364.72	365.46	302.37	298.87	368.24	364.09
Other Revenue	0.46	0.46	0.43	0.37	0.93	0.52
Revenue	365.18	365.92	302.79	299.24	369.17	364.62
Revenue Growth	3.90%	20.85%	1.19%	-18.94%	1.25%	7.51%
Cost of Revenue	197.81	177.72	126.41	135.91	177.29	181.17
Gross Profit	167.37	188.2	176.38	163.33	191.88	183.45
Selling, General & Admin	83.72	71.32	67.9	58.03	56.86	63.26
Research & Development	48.59	35.71	36.33	34.19	22.09	27.15
Other Operating Expenses	3.16	5.57	5.27	4.92	3.76	3.06
Operating Expenses	136.96	115.64	106.35	98.94	83.43	93.81
Operating Income	30.41	72.56	70.03	64.39	108.45	89.64
Interest Expense	-0	-0.14	-0.25	-0.5	-0.41	-0.44
Interest & Investment Income	9.86	22.05	28.34	30.13	12.82	18.35
Other Non Operating Income (Expenses)	4.5	-0.01	-0.03	-0.05	-0.05	-0.04
EBT Excluding Unusual Items	44.78	94.45	98.08	93.97	120.81	107.52
Gain (Loss) on Sale of Investments	3.75	1.62	2.01	1.26	0.17	1.55
Gain (Loss) on Sale of Assets	-0.01	-	0.65	0.03	-0.01	11.2
Asset Writedown	-0.02	-0.02	-0.31	-0	-0	-0.15
Other Unusual Items	5.32	7.78	8.39	6.78	4.69	4.06
Pretax Income	53.82	103.83	108.83	102.04	125.66	124.17
Income Tax Expense	-0.22	9.31	14.47	8.56	15.76	14.63
Earnings From Continuing Operations	54.04	94.52	94.36	93.48	109.89	109.54
Net Income	54.04	94.52	94.36	93.48	109.89	109.54
Net Income to Common	54.04	94.52	94.36	93.48	109.89	109.54
Net Income Growth	-45.63%	0.17%	0.94%	-14.93%	0.32%	13.42%
Shares Outstanding (Basic)	257	263	262	267	224	222
Shares Outstanding (Diluted)	257	263	262	267	224	222
Shares Change	-1.74%	0.17%	-1.87%	19.09%	1.00%	16.50%
EPS (Basic)	0.21	0.36	0.36	0.35	0.49	0.49
EPS (Diluted)	0.21	0.36	0.36	0.35	0.49	0.49
EPS Growth	-44.67%	0%	2.86%	-28.57%	-0.67%	-2.65%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Free Cash Flow	-27.95	-172.68	-69.38	-71.21	64.28	42.7
Free Cash Flow Per Share	-0.11	-0.66	-0.27	-0.27	0.29	0.19
Dividend Per Share	0.100	0.100	0.150	0.150	0.200	0.333
Dividend Growth	-33.33%	-33.33%	0%	-25.00%	-39.99%	-10.02%
Gross Margin	45.83%	51.43%	58.25%	54.58%	51.98%	50.31%
Operating Margin	8.33%	19.83%	23.13%	21.52%	29.38%	24.59%
Profit Margin	14.80%	25.83%	31.16%	31.24%	29.77%	30.04%
Free Cash Flow Margin	-7.65%	-47.19%	-22.91%	-23.80%	17.41%	11.71%
EBITDA	68.9	105.21	94.91	82.87	125.09	104.55
EBITDA Margin	18.87%	28.75%	31.35%	27.69%	33.88%	28.68%
D&A For EBITDA	38.48	32.65	24.88	18.48	16.64	14.91
EBIT	30.41	72.56	70.03	64.39	108.45	89.64
EBIT Margin	8.33%	19.83%	23.13%	21.52%	29.38%	24.59%
Effective Tax Rate	-	8.97%	13.30%	8.39%	12.55%	11.79%
Revenue as Reported	98.53	365.92	302.79	299.24	369.17	364.62
Advertising Expenses	-	19.85	18.08	19.22	7.92	9.94